AM6 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Amicus Therapeutics Inc

Watchlist Manager

Watchlist

Price: 12 EUR Market Closed

Market Cap: €3.6B

A	Amicus Therapeutics Inc XBER:AM6	US
	Angstrom Technologies Inc OTC:AGTT	US
	Taiyo Koki Co Ltd TSE:6164	JP
E	Egide SA LSE:0OJ4	FR
I	Iflex Flexible Packaging SA MAD:IFLEX	ES
R	Robertet SA PAR:CBR	FR
	Freeman Gold Corp F:3WU	CA

Profitability Summary

Amicus Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

90%

Declining Gross Margin

89% > 89%

Low Operating Margin

Negative 3Y Average Operating Margin

-4%

Operating Margin is Increasing

-38% > 5%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-20%

Net Margin is Increasing

-53% > -4%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-11%

Free Cash Flow Margin is Increasing

-38% > 5%

Negative ROE

-12%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-82%

Declining ROIC

-30% > -852%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

90%

Declining Gross Margin

89% > 89%

Low Operating Margin

Negative 3Y Average Operating Margin

-4%

Operating Margin is Increasing

-38% > 5%

Negative Net Margin